Effect of metformin on apoptosis induction in ovarian cancer cells

Przeglad Menopauzalny

Volumn 13, Issue 3, 2014, Pages 155-161

  Rogalska, Aneta ^a   Forma, Ewa ^a   Ciesielski, Piotr ^a   Brys̈, Magdalena ^a   Krzes̈lak, Anna ^a   Marczak, Agnieszka ^a  

^a UNIVERSITY OF LODZ   (Poland)

Author keywords

Apoptosis; BIRC5; Metformin; Ovarian cancer; SKOV 3; Survivin

Indexed keywords

4 [5 (4 METHYL 1 PIPERAZINYL)[2,5' BI 1H BENZIMIDAZOL] 2' YL]PHENOL; FLUOROCHROME; METFORMIN;

APOPTOSIS; ARTICLE; BIRC5 GENE; CELL SHAPE; CONTROLLED STUDY; DRUG EFFECT; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; OVARIAN CANCER CELL LINE; OVARY CANCER;

EID: 84924714724     PISSN: 16438876     EISSN: 22990038     Source Type: Journal    
DOI: 10.5114/pm.2014.43817     Document Type: Article

References (37)

1. Franciosi M, Lucisano G, Lapice E, et al. Metformin therapy and risk of cancer in patients with type 2 diabetes: systematic review. PLoS One 2013; 8: e71583.
2. Dowling RJ, Zakikhani M, Fantus IG, et al. Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells. Cancer Res 2007; 67: 10804-10812.
3. Gotlieb WH, Saumet J, Beauchamp MC, et al. In vitro metformin antineoplastic activity in epithelial ovarian cancer. Gynecol Oncol 2008; 110: 246-250.
4. Zakikhani M, Dowling R, Fantus IG, et al. Metformin is an AMP kinasedependent growth inhibitor for breast cancer cells. Cancer Res 2006; 66: 10269-10273.
5. Leclerc GM, Leclerc GJ, Kuznetsov JN, et al. Metformin induces apoptosis through AMPK-dependent inhibition of UPR signaling in ALL lymphoblasts. PLoS One 2013; 8: e74420.
6. Ben Sahra I, Le Marchand-Brustel Y, Tanti JF, et al. Metformin in cancer therapy: a new perspective for an old antidiabetic drug Mol Cancer Ther 2010; 9: 1092-1099.
7. Tomic T, Botton T, Cerezo M, et al. Metformin inhibits melanoma development through autophagy and apoptosis mechanisms. Cell Death Dis 2011; 2: e199.
8. Cazzaniga M, Decensi A, Pruneri G, et al. The effect of metformin on apoptosis in a breast cancer presurgical trial. Br J Cancer 2013; 109: 2792-2797.
9. Marczak A, Bukowska B. New trends in the ovarian cancer treatment. Prz Menopauzalny 2013; 6: 489-492.
10. Liu B, Fan Z, Edgerton SM, et al. Metformin induces unique biological and molecular responses in triple negative breast cancer cells. Cell Cycle 2009; 8: 2031-2040.
11. Wang LW, Li ZS, Zou DW, et al. Metformin induces apoptosis of pancreatic cancer cells. World J Gastroenterol 2008; 14: 7192-7198.
12. Hanna RK, Zhou C, Malloy KM, et al. Metformin potentiates the effects of paclitaxel in endometrial cancer cells through inhibition of cell proliferationand modulation of the mTOR pathway. Gynecol Oncol 2012; 125: 458-469.
13. Karczmarek-Borowska B, Zmorzyski Sz, Filip A. Biologiczna rola surwiwiny. Wspócz Onkol 2008; 12: 437-440.
14. Li F. Survivin study: what is thenext wave J Cell Physiol 2003; 197: 8-29.
15. Fennell DA. Caspase regulation in non-small cell lung cancer and its potential for therapeutic exploration. Clin Cancer Res 2005; 11: 2097-2105.
16. Denel M, Marczak A. Panels od protein biomarkers and non-protein markers in the diagnosis of the ovarian cancer. Prz Menopauzalny 2013; 17: 404-408.
17. Carmichael J, DeGraff WG, Gazdar AF, et al. Evaluation of a tetrazoliumbased semiautomated colorimetric assay: assessment of radiosensitivity. Cancer Res 1987; 47: 943-946.
18. Gasiorowski K, Brokos B, Kulma A, et al. A comparison of the methods applied to detect apoptosis in genotoxically-damaged lymphocytes cultured in the presence of four antimutagens. Cell Mol Biol Lett 2001; 6: 141-159.
19. Owen MR, Doran E, Halestrap AP. Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain. Biochem J 2000; 348: 607-614.
20. Serkies K, Sinacki M, Jassem J. The role of hormonal factors and endocrine therapy in ovarian cancer. Wspolcz Onkol 2013; 17: 14-19.
21. Gottwald L, Danilewicz M, Fendler W, et al. The AgNORs count in predicting long-term survival in serous ovarian cancer. Arch Med Sci 2014; 10: 84-90.
22. Woniak S, Szkodziak P, Czuczwar P, et al. Ovarian tumor in women of the late childbearing age: how to assess the risk of cancer. Prz Menopauzalny 2013; 12: 78-82.
23. Rogala E, Nowicka A, Bednarek W, et al. Evaluation of the expression of the immunosuppressive enzyme - indoleamine 2,3-dioxygenase in ovarian cancer tissue. Prz Menopauzalny 2013; 12: 223-227.
24. Pawaowska M, Markowska A. The influence of metformin in the etiology of selected cancers. Wspolcz Onkol 2012; 16: 223-229.
25. Ferreira GD, Germeyer A, de Barros Machado A, et al. Metformin modulates PI3K and GLUT4 expression and Akt/PKB phosphorylation in human endometrial stromal cells after stimulation with androgen and insulin. Eur J Obstet Gynecol Reprod Biol 2014; 175: 157-162.
26. Shafiee MN, Khan G, Ariffin R, et al. Preventing endometrial cancer risk in polycystic ovarian syndrome (PCOS) women: could metformin help Gynecol Oncol 2014; 132: 248-253.
27. Milewicz T, Kiaka M, Mroziska S, et al. Metformin - new treatment strategies for gynecologic neoplasms. Przegld Lekarski 2013; 70: 81-84.
28. Dilokthornsakul P, Chaiyakunapruk N, Termrungruanglert W, et al. The effects of metformin on ovarian cancer: a systematic review. Int J Gynecol Cancer 2013; 23: 1544-1551.
29. Zhang Z, Li S. The prognostic value of metformin for cancer patients with concurrent diabetes: a systematic review and meta-analysis. Diabetes Obes Metab 2014. doi: 10.1111/dom.12267 [Epub ahead of print].
30. Rattan R, Graham RP, Maguire JL, et al. Metformin suppresses ovarian cancer growth and metastasis with enhancement of cisplatin cytotoxicity in vivo. Neoplasia 2011; 134: 83-91.
31. Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol 2007; 35: 495-516.
32. Yasmeen A, Beauchamp MC, Piura E, et al. Induction of apoptosis by metformin in epithelial ovarian cancer: involvement of the Bcl-2 family proteins. Gynecol Oncol 2011; 121: 492-498.
33. Portt L, Norman G, Clapp C, et al. Anti-apoptosis and cell survival: a review. Biochim Biophys Acta 2011; 1813: 238-259.
34. Dohi T, Beltrami E, Wall NR, et al. Mitochondrial survivin inhibits apoptosis and promotes tumorigenesis. J Clin Invest 2004; 14: 1117-1127.
35. Nair V, Pathi S, Jutooru I, et al. Metformin inhibits pancreatic cancer cell and tumor growth and downregulates Sp transcription factors. Carcinogenesis 2013; 34: 2870-2879.
36. Mckay TR, Bell S, Tenev T, et al. Procaspase 3 expression in ovarian carcinoma cells increases survivin transcription which can be countered with a dominant-negative mutant, survivin T34A; a combination gene therapy strategy. Oncogene 2003; 22: 3539-3547.
37. Zhang W, Chen X, Giu F. An antisense plasmid targeting survivin expression induces apoptosis and sensitizes hepatocarcinoma cells to chemotherapy. J Huazhong Univ Sci Technolog Med Sci 2003; 23: 387-391.